Developing new medications can take years. But computational biologist Aviv Regev says AI-powered cell mapping is ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Biogen Inc. and Genentech Inc. are heading to trial in June over a significant contract dispute concerning patent royalties ...

Historically, BPDCN treatment relied on chemotherapy regimens adapted from leukemia or lymphoma protocols. However, recent breakthroughs have transformed the treatment paradigm. ELZONRIS (Stemline ...

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...

The company has a long history of leading HR policy changes. Now it is kowtowing to the president's anti-DEI stand.